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Abstract 
Background: Despite the evidence-based value of cervical cancer screening, recent updates to 
guidelines, and general availability of the Papanicolaou (Pap) test, guideline-adherent screening 
rates remain low. The COVID-19 pandemic further impedes progress as preventive healthcare is 
delayed and patients are reluctant to enter healthcare facilities. Objectives: The purpose of this 
project was to evaluate if provider education and patient reminder letters comprising written 
education and risk-mitigation efforts improved cervical cancer screening rates and increased 
providers’ knowledge of appropriate follow-up during reopening of a metro family practice 
clinic amid the COVID-19 pandemic. Methods: A multi-faceted quality improvement project 
included a 3-month intervention phase comprised of: (1) provider education with descriptive 
analysis of pre- and post-intervention knowledge of cervical cancer screening scores as well as, 
(2) distribution of reminder letters to 295 eligible patients. Results: The overall cervical cancer 
screening rate increased by 1% during the 3-month period. Provider questionnaire scores noted a 
significant increase in knowledge and intent to change practice patterns (p<.05) and confirmed a 
significant improvement in providers’ knowledge of cervical cancer screening and management 
of abnormal cervical cytology/histology following implementation of provider education 
(p<.05). Conclusion: Findings indicate that provider education improves knowledge of cervical 
cancer screening and follow-up, as well as, fosters an intent to change practice patterns according 
to established guidelines. Reminder letters did provide a modest increase in cervical cancer 
screening rates during the COVID-19 pandemic suggesting that written education and risk-
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Introduction 
Human papillomavirus (HPV) is the most common sexually transmitted virus worldwide 
(World Health Organization, 2014) and ordinarily presents without symptoms. There are 100 
types of HPV, 14 of which can cause cancer (World Health Organization, 2014). HPV either 
resolves spontaneously or remains as a persistent infection. Cervical cancer is primarily caused 
by persistent infection with “high risk” HPV; therefore, cervical cancer is largely preventable by 
vaccinating against HPV and by screening for precancerous lesions. Based on the woman’s age 
and medical history, a cytological Papanicolaou (Pap) test and/or an HPV test are performed for 
cervical cancer screening.  
In cases of cervical precancer, a distinct change in the epithelial cells of the 
transformation zone of the cervix is identified (World Health Organization, 2014). Precancerous 
changes of the cervix are classified as cervical intraepithelial neoplasia (CIN) and are graded by 
severity, from CIN1 to CIN3, with CIN3 being carcinoma in situ (Nardi et al., 2016). Cervical 
precancer may last several (10-20) years before progressing to invasive cancer, thus allowing 
ample opportunity for screening, detection and treatment (World Health Organization, 2014). 
The incidence of cases and deaths from cervical cancer have decreased in response to effective 
screening and treatment, yet cervical cancer remains one of the leading causes of cancer death in 
women worldwide (World Health Organization, 2014). This statistic is especially problematic in 
the wake of COVID-19, a global pandemic, which has prompted a sharp decline in preventive 
care. Health systems around the world are prioritizing urgent visits and delaying elective care in 
an effort to reduce COVID-19 transmission within healthcare settings. Telemedicine has become 
the gold standard; however, such visits have great limitations when it comes to preventive care 
such as Pap testing for cervical cancer screening. 
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Background and Significance 
Healthy People 2020 set a target goal of screening 93% of women for cervical cancer 
according to the recommended guidelines (Nardi et al., 2016). COVID-19 threatens the 
achievement of this goal as preventive healthcare is delayed and patients are reluctant to enter 
healthcare facilities amid a global pandemic. Approximately 1 in 3 Americans have put off 
regular health care during COVID-19 (Kaiser Health News, 2020).  Suspending cancer 
screenings indefinitely could lead to a surge of patients with delayed diagnoses and unfavorable 
outcomes. Within the new landscape of COVID-19, striving towards the Healthy People 2020 
cervical cancer screening goal requires exploration and alleviation of barriers to guideline-
consistent screening. Apart from fear of COVID-19 transmission, patient-level barriers include 
inadequate knowledge of the role of cancer screening, anxiety surrounding abnormal results, 
anticipation of discomfort during pelvic exam, embarrassment, perceived cost and access to 
services (Nardi et al., 2016). Access and cost are further affected by busy work schedules, lack of 
insurance and being unemployed (Brown et al, 2011). The leading provider-level barrier is poor 
understanding of complex cervical cancer screening and management guidelines (MacLaughlin 
et al., 2018). This provider-level barrier is further complicated by overseeing unfamiliar patients 
of colleagues who have been redeployed or are working remotely from home during the 
pandemic. 
Social factors greatly influence the differential risk of contracting COVID-19 with the 
most vulnerable members of society hit the hardest. Those with social disadvantage have been 
found to underuse primary care and overuse hospital-based care (Pampel et al., 2010). Preventive 
visits are slowly reactivating in areas where the rate of new COVID-19 cases is controlled, yet 
this patient population continues to evade primary care. Wong et al (2020) conducted semi-
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structured phone interviews with patients identified through purposive sampling to understand 
changes in behavior and attitudes towards healthcare since the start of the COVID-19 pandemic. 
It was found that healthcare settings are perceived as infectious reservoirs and patients are not 
well-informed of the current risk-mitigation efforts at such settings (Wong et al, 2020). 
Low socio-economic status (SES) underlies key determinants of health including health 
care, health behavior and environmental exposure. The cumulative effects of social disadvantage 
across stages of the life cycle present immense challenges for an urban practice site and its 
healthcare providers. Providers are responsible for managing a great level of biomedical 
morbidity while confronting and navigating a complicated web of psychosocial barriers. 
Minority populations are disproportionately affected by cervical cancer (Nardi et al., 2016). 
“Black women account for 8.9 of 100,000 new cases and the incidence in Hispanic women is 9.4 
per 100,000 cases, compared with 7.5 per 100,000 cases for white women” (Nardi et al., 2016). 
Screening rates are also lower for Hispanic and African American women at 77% and 82.13%, 
respectively (Nardi et al., 2016). A number of economists claim that “the lower lifetime earnings 
and wealth of low-SES groups give them less reason to invest in future longevity and more 
reason to focus on the present in making decisions about health behaviors” (Pampel et al., 2010). 
Cervical cancer yields substantial economic burden on the population and the nation’s 
health system. In 2019, an estimated 13,170 cases of invasive cervical cancer were diagnosed in 
the United States with an estimated 4,250 deaths (American Cancer Society, 2019). A mixed 
methods study performed by Nwankwo et al (2019) revealed that “total healthcare costs were 
$4,221 higher, and an additional 0.37 workdays were missed in women with cervical cancer 
compared to propensity-matched controls.” Increasing compliance with cervical cancer screening 
guidelines is cost effective. According to Chesson et al (2012), approximately 52 million Pap 
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tests are performed in the U.S. annually with an average cost of $103 per cervical cancer 
screening. Compared to nonadherent screening practices, guideline-based cytologic screening 
results in greater cancer prevention (80.9% incidence reduction; 86.7% mortality reduction) and 
a lower incremental cost-effectiveness ratio (ICER) (Kim et al., 2015). In the setting of value-
based care and increased pressure to reduce healthcare costs, the cost-saving potential of proper 
preventive care should not be overlooked. 
Needs Assessment 
A needs assessment was conducted to evaluate the strengths, weaknesses, opportunities, 
and threats (SWOT), as well as, identify the barriers and facilitators for conducting the proposed 
project at RiverCenter clinic. The following report is illustrated as a SWOT diagram in Appendix 
A. 
Barriers 
Advocate Aurora Health - RiverCenter clinic manages a large volume of patients, many 
of whom are of low SES with subsequent disparities in health status, morbidity and mortality. 
Health disparity translates to increased medical complexity and extensive active problem lists. 
Low SES is associated with less utilization of preventative and early detection services 
(American Psychological Association, 2020). Low SES impacts transportation, insurance status, 
ability to pay and access to medical screening (American Psychological Association, 2020). 
Missed appointments and insurance gaps as well as cost of diagnostic testing and follow-up 
notably reduce rates of health maintenance adherence.  
RiverCenter experienced a surge in primary care provider (PCP) turn-over due to 
relocation and early retirement in the setting of a global pandemic, thus increasing the risk of 
patients lost to follow-up. Moreover, COVID-19 led to the expansion of telehealth or virtual care 
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and the redeployment of several primary care providers. Consequently, preventive exams 
requiring an in-person appointment such as cervical cancer screening have been deferred with 
under-utilization of important medical services. The system lacked standardization for 
communicating the need for cervical cancer screening. Lack of consistent processes impeded 
effective outreach and patient education to ensure periodic care is performed based on level of 
risk. RiverCenter is a busy practice, which increases the number of competing demands and 
reduces the availability of providers, ancillary staff members and leadership.   
Facilitators 
RiverCenter encompasses a strong team-work mentality founded on a culture of 
collaboration. The loss of multiple PCPs and medical assistants gave rise to an influx of new 
employees who are motivated to excel and eager to learn. RiverCenter is equipped with an 
experienced, efficient and diverse Registered Nurse (RN) staff. RNs triage, offer comprehensive 
education and work directly with PCPs to coordinate patient care. RiverCenter has an on-site 
application support information technologist, a quality improvement representative and an 
organizational nursing research scientist who are well-versed in data retrieval, analysis and 
management. RiverCenter maintains meaningful use of an interoperable electronic medical 
record (EMR) as proposed by the Health Information Technology for Economic and Clinical 
Health (HITECH) Act.  
Advocate Aurora Health established a robust ambulatory reactivation plan across its 
clinical sites including a Safe Care Promise, which details mandatory safety measures that have 
been implemented to protect patients seeking care and team members providing care during 
COVID-19.  Leadership has a clear vision of success, supports professional development and is 
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committed to continuous growth of the organization. Leadership prioritizes interpersonal, 
transparent and consistent communication.  
Problem  
Cervical cancer screening has reduced the incidence of cervical cancer death by more 
than 60% since its introduction in the 1950s (Rosenberg, 2019). Evidence shows that cervical 
cancer mortality typically occurs among unscreened women. According to the American Cancer 
Society (2019), early detection through Pap testing greatly increases the five-year survival rate 
for women with cervical cancer. When cervical cancer is diagnosed as localized, the five-year 
survival rate is 92% (American Cancer Society, 2019). If the cancer spreads to a different part of 
the body, the five-year survival rate is reduced to 57.4% (Nardi et al., 2016). Despite the 
evidence-based value of cervical cancer screening, recent updates to guidelines, and general 
availability of the Pap test, guideline-adherent screening rates remain low (Rosenberg, 2019). 
During COVID-19, guideline-adherent cervical cancer screening rates dropped even further 
across the United States. Appointments for cervical cancer screening fell by 94% compared to 
the 2017-2019 averages (Epic Health Research Network, 2020). If this trend continues, many 
cancer cases will likely go undiagnosed or be diagnosed at a later stage with a poorer prognosis 
(Epic Health Research Network, 2020).  
Erroneous cervical cancer screening practices yield substantial consequences. As reported 
by Subramaniam et al (2011), approximately 50% of invasive cervical malignancies are 
diagnosed in patients that have never been screened and 10% of the remaining cervical cancer 
patients have not had a Pap smear in the five years prior to diagnosis. Conversely, over-screening 
yields needless healthcare expenditures, patient inconvenience as well as potential patient harm 
from false-positive results and subsequent unnecessary invasive procedures (Hills et al., 2015). 
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Evidence from review of the literature deemed provider training, patient education and 
patient reminders to be successful methods for enhancing appropriate cervical cancer screening. 
A needs assessment conducted within RiverCenter family practice clinic revealed the need to 
implement such strategies to increase the rate of guideline-consistent cervical cancer screening 
and follow-up during its reactivation. RiverCenter’s cervical cancer screening quality 
improvement data revealed a Pap completion rate of 87% for August 2020, which was expected 
to decline in the setting of delayed preventive care visits.  
Purpose 
The purpose of this project was to evaluate if provider training as well as patient 
reminders comprising written education and risk-mitigation efforts improved guideline-
consistent cervical cancer screening rates and increased providers’ knowledge of appropriate 
follow-up among eligible female patients during reopening of a large metro family practice clinic 
in the wake of COVID-19.  
Aims 
 The first aim was to meet or exceed Healthy People 2020’s target goal of screening 93% 
of eligible female patients for cervical cancer by January 2021. The second aim was to improve 
providers’ knowledge of guideline-consistent routine screening and follow-up for abnormal Pap 
testing by 10% from baseline. 
Literature Review 
Review of the Evidence 
A literature review was conducted in order to systematically investigate evidence of best 
practice concerning interventions for improving guideline-consistent cervical cancer screening 
rates and follow-up of abnormal results within the primary care setting. Review of the literature 
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focused on provider training, patient education and patient reminders as means to increase 
cervical cancer screening rates. Articles were searched from PubMed and CINAHL. Preceding 
the search, a librarian was consulted and subsequently advised exploration of these databases. 
Articles were accessed through the Himmelfarb Health Sciences Library website and search 
strategies were tailored according to each individual database. Several keywords were utilized, in 
various combinations, while searching the databases: papanicolaou (pap) smear, pap testing, 
clinical decision support, cervical cancer, cervical cancer screening, training, education, 
reminder, abnormal pap, provider adherence and guidelines. Keywords were connected with the 
Boolean operators “and” and “or.” A total of 445 citations were initially identified. It is 
important to note that the number of citations generated was contingent on the specific variation 
of keywords used. To make the screening process less cumbersome, pertinent titles and abstracts 
of articles in each database were explored further and accepted or rejected based on inclusion 
and exclusion criteria. Duplicate studies were then eliminated. As a result of such editing, 
approximately 15 articles were deemed relevant. The Johns Hopkins evidence appraisal tool was 
used to evaluate the strength of the literature. Among the relevant articles, 5 were rejected for 
inferior quality and disparate outcome measures. The articles that were identified are organized 
into a table of evidence in Appendix B. 
Eligible studies referenced compliance with outpatient cervical cancer screening among 
biological females. More specifically, eligible studies were written in English, of USA or Canada 
geographic subset, published within the last 10 years and offered access to full-text. Ineligible 
studies included those that examined, exclusively, patient education interventions other than 
written material and patient outreach via phone call. Studies were discarded if they focused on a 
specific patient ethnicity other than ethnically diverse black women. Studies focusing on black 
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women were considered applicable as RiverCenter is a city-based clinic serving a large 
percentage of ethnically diverse black patients. Furthermore, it is of value to understand cervical 
cancer screening rates from an ethnically diverse perspective in view of epidemiological data, 
which shows that black women have high rates of cervical cancer and are more likely to die from 
the disease than women of other races (Brown et al., 2011). There is a well-defined association 
between inadequate screening and socioeconomic, geographic and racial disparities (Hills et al., 
2015). Female patients who have low income and educational level, those who are uninsured, 
and those who have immigrated to the United States in the past 10 years account for the majority 
of cervical cancer cases (National Center for Health Statistics, 2011).   
Provider Knowledge, Adherence and Training 
Risk for developing cervical cancer rises exponentially in women who have never 
received screening, have been screened erroneously, and have delayed or no follow-up of 
abnormal results (MacLaughlin et al., 2018). Studies of clinician application of the American 
Cancer Society (ACS) and the American Society for Colposcopy and Cervical Pathology 
(ASCCP) screening guidelines reflect low levels of understanding and compliance (Teoh et al., 
2015). A non-experimental cross-sectional survey conducted by Boone et al. (2016) determined 
that distrust and confusion likely limit adherence to current evidence-based cervical cancer 
screening health policy recommendations. A total of 4,909 randomly selected primary care 
providers (physicians, nurse practitioners, and physician assistants) practicing in California were 
mailed a study questionnaire. Of the 1,268 qualified responses received, 35.0% of all primary 
care providers deemed current guidelines clinically inappropriate. Among those who 
affirmatively believed current guidelines were “authoritative, reliable, and clinically 
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appropriate,” only 15.3% recommended screening intervals consistent with that of current policy 
guidelines (Boone et al., 2016). 
Teoh et al (2015) performed a similar survey-based study, which sought to evaluate 
knowledge, reported practices, and interpretations of the 2012 cervical cancer screening 
guidelines among 325 health care providers in a large health maintenance organization. Of the 
124 respondents, 12.1% reported they were not aware of the 2012 guideline changes and only 
5.7% answered all the knowledge questions correctly. A majority of respondents reported correct 
screening practices in the 21–29 year patient age group (65.8%) and in the >65 year patient age 
group (74.3%). Appropriate screening intervals in the 30–65 year patient age group varied by 
modality, with 89.3% correctly screening every 3 years with Pap smear alone, but only 57.4% 
correctly screening every 5 years with Pap smear and human papillomavirus contesting (2015). 
Across all patient age groups, the most frequently cited reasons for poor adherence were lack of 
knowledge of the guidelines and patient demand for a different screening interval. As the patient 
age group increased, a greater percentage of providers reported patient demand as a reason for 
guideline nonadherence. As the patient age group increased, a lesser percentage of providers 
reported lack of knowledge as a reason for guideline nonadherence. Hills et al. (2015) found that 
individual provider educational outreach in a primary care setting contributes to a decrease in 
over-screening (9.8% to 2.9%) and under-screening (52.1% to 24.7%) among patients with a 
high vulnerability risk profile. White and Kenton (2013) implemented changes to the EMR and 
delivered lectures to educate providers on cervical cancer screening guidelines. Following this 
intervention, the total number of Pap tests done on adolescents decreased by 34% and 
appropriate follow-up for abnormal results improved by 8%. However, the overall numbers of 
abnormal results were very low, making it difficult to determine whether any improvements in 
CERVICAL CANCER SCREENING 14 
management truly related to the implemented EMR changes (White & Kenton, 2013). Because 
this was a retrospective review of all screened adolescents during a single calendar year rather 
than following a group of specific physicians' practice patterns over a period, the study is unable 
to control for changes in faculty and resident staff (White & Kenton, 2013). 
Patient Education and Reminders 
 Some studies focused on the importance of considering a patient’s cultural beliefs and 
practices when examining barriers and designing educational programs for cervical cancer 
screening. Brown et al. (2011) conducted six focus groups with forty-four Haitian, African, 
English-speaking Caribbean and African American women recruited from a federally qualified 
health center in Essex County, New Jersey. The small, qualitative sample of primarily low-
income black women may limit the generalizability of this study; however, the following 
findings are still thought-provoking. Brown et al. (2011) discovered that all ethnic groups 
possessed limited knowledge and confusion about cervical cancer, risk factors, Pap testing and 
human papillomavirus (HPV). Still, differences between ethnic groups in knowledge, cultural 
beliefs and practices were evident. These findings suggest the need to provide culturally-based 
information about the importance of screening and its role in maintaining one’s personal health. 
A systematic review and metanalysis performed by Musa et al. (2017) similarly 
examined the use of culturally-sensitive, linguistically-diverse education and its positive 
influence on patient participation in cervical cancer screening. The use of theory-based education 
increased cervical cancer screening rates by over 50% and sending invitation/reminder letters to 
patients similarly increased the uptake of cervical cancer screening (Musa et al., 2017). A 
systematic review of interventional studies performed by Ghare et al. (2018) concluded that 
developing patient knowledge and promoting patient awareness through educational intervention 
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and clear communication leads to a change in health behavior (2018). Mailed patient reminders 
increased Pap testing usage by 18.8% (Ghare et al., 2018).  
Other studies indicated that educating patients with written materials may be a beneficial 
way to improve cervical cancer screening rates. Mazor (2014) conducted a randomized 
controlled trial among 527 insured women ages 40 to 65 years in Georgia, Massachusetts, 
Hawaii and Colorado with the intent to investigate the association between health literacy and 
cervical cancer screening. Forty-five percent of the women in this study had at least a bachelor’s 
degree and 42% reported their race as white, non-Hispanic. Spoken health literacy was 
associated with screening behaviors in this population, suggesting that it has independent effects 
beyond those of access to care. Women in the study had difficulty understanding spoken 
recommendations about cancer screening. The authors concluded that education written in plain-
language may be beneficial for all regardless of health literacy level. Feldmen et al. (2017) 
cultivated education and communication through implementation of mailed personalized recall 
letters and inclusion of educational brochures for eligible patients in a multi-site urban practice. 
Cervical cancer screening rates increased from 60% pre-intervention to 71% (p<0.05) post-
intervention. 
Several congruent themes emerged from the literature. Providers’ lack of knowledge, 
misinterpretation and distrust contributes to poor adherence to current cervical cancer screening 
guidelines. The complexity of the current algorithms for cervical cancer screening and 
management of abnormal results warrants further provider training. Patient knowledge about 
cervical cancer and its risk factors, the Pap test, and the human papillomavirus (HPV) is limited. 
Personalized reminder letters for patients as well as provider and patient educational outreach are 
similarly effective methods to increase cervical cancer screening rates. Of note, patients often 
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have difficulty understanding spoken recommendations about cancer screening; therefore, 
greater benefit is gained from written education using simple language. 
Evidence-Based Practice Model 
The Johns Hopkins Nursing Evidence-Based Practice Model 
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model was selected to 
guide implementation of this project. JHNEBP fosters a problem-solving approach to clinical 
decision making by utilizing a three-step process called PET: practice question, evidence and 
translation (Dang & Dearholt, 2017). The goal of this model is to effectively incorporate the 
latest research findings and best practices into patient care (Dang & Dearholt, 2017).  
Practice Question 
Within a large family practice clinic that is reopening in-person preventive care visits 
during COVID-19, does implementing provider training and patient reminders comprising 
written education and risk-mitigation efforts increase guideline-consistent cervical cancer 
screening rates and enhance providers’ understanding of appropriate follow-up among eligible 
female patients ages 21-64 years? 
Evidence 
 Literature was explored to address the derived practice question. Articles were then 
reviewed and appraised using the Johns Hopkins Evidence and Quality Guide (Dang & Dearholt, 
2017). Each article received strength of evidence as well as quality rating scores. Level I 
constitutes the strongest level of evidence and includes randomized controlled trials or meta-
analysis of randomized control trials. Level II is comprised of quasi-experimental studies. Level 
III contains non-experimental and qualitative studies as well as meta-synthesis of qualitative 
research. Level IV reflects the opinion of nationally recognized experts based on research 
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evidence. Level V reflects the opinion of individual expert based on non-research evidence. Each 
scientific evidence is also assigned a quality rating of A, B, or C. The highest quality evidence is 
assigned to articles with consistent and definitive results, adequate sample size, and extensive 
review of literature reflecting scientific evidence. Through review of the literature, it was 
determined that sufficient higher-level evidence exists to suggest that provider training, patient 
education and patient reminders are successful methods for enhancing appropriate cervical 
cancer screening. 
Translation 
 This step involved determining the viability of translating recommendations into the 
specific practice setting. An action plan was created and implemented. Milestones were assigned 
a scheduled time for completion and pre/post observable measures were identified. Outcomes 
and positive findings were then disseminated. Please refer to the Methods and Evaluation 
sections for further details.  
Methods 
Design 
The methodology chosen for this project was based on the literature search, which 
supported provider training and patient reminders comprising written education as interventions 
to increase guideline-consistent cervical cancer screening rates and improve providers’ 
knowledge of managing abnormal cervical cytology/histology amid reopening of in-person 
preventive care visits at a large metro family practice clinic. Such interventions were derived 
from empirical and theoretical review of the literature. The project design is a multi-faceted, 
institution-based quality improvement project. 
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Setting 
This quality improvement (QI) project was conducted at Aurora Health Center - 
RiverCenter, a large family practice clinic in metro Milwaukee, Wisconsin. Advocate Aurora 
Health is one of the ten largest not-for-profit integrated health systems in the United States. The 
zip code (53212) in which RiverCenter clinic is located has been designated as a lower 
socioeconomic status (SES) precinct with a large population density (Greer et al, 2013). 
Individuals residing within this zip code are primarily African American with a median 
household income of $29,653 and an unemployment rate above the state average (United States 
Zip Codes, 2020). Fifty-one percent of the population is female, while 49% are male (United 




Inclusion criteria for patients who were identified to receive written education and 
reminders consisted of females ages 21-64 years with a listed primary care provider at 
RiverCenter clinic. Such patients must have been evaluated in-person by a provider at 
RiverCenter clinic on at least 2 separate occasions. Exclusion criteria for patients included 
history of total hysterectomy (unless procedure was performed as treatment for cervical pre-
cancer or cancer) or retaining a hospice code within the last 12 months. According to August 
2020 clinic data there were 2,268 eligible female patients, 295 of whom were overdue for 
cervical cancer screening.  
Providers  
Primary care providers (two female nurse practitioners, two female physician assistants, 
two male physicians, and four female physicians) employed by RiverCenter clinic were invited 
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to participate in a questionnaire/survey and education intervention. In order to meet study 
eligibility criteria, providers must work at least a 0.5 full-time equivalent (FTE) as a primary care 
provider at RiverCenter clinic. 
Interventions 
A methodology map of the following interventions can be found in Appendix C. 
Patient Reminder Letters 
The overall clinic’s monthly cervical cancer screening compliance score (%) was 
calculated by the clinic’s Quality Improvement Representative (QIR). The QIR identified all 
eligible females due for cervical cancer screening using an electronic query of the electronic 
medical record (EMR). The cervical cancer screening score for August 2020 served as the 
clinic’s baseline (pre-intervention) data. As of August 2020, 87% of 2,268 total eligible patients 
at RiverCenter clinic received cervical cancer screening according to guidelines; therefore, 295 
patients remained overdue for cervical cancer screening.  
A patient reminder letter was created with a description of risk mitigation efforts in place 
during COVID-19 and an educational brochure on cervical cancer screening approved by 
Advocate Aurora Health (Appendix D). This letter was then imported into the EMR for 
convenience. The QIR delivered identifiable data of patients due for cervical cancer screening 
directly to two selected front desk agents, also known as Patient Service Representatives (PSR), 
who then accessed the letter in the EMR and executed the reminder mailing process. Aside from 
assembling and mailing patient reminder letters, the PSRs also manually tracked letters sent. 
Provider Education and Questionnaire  
REDCAP software was utilized to create a modified pre- and post-education provider 
questionnaire based on the National Survey of Primary Care Physicians’ Cancer Screening 
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Recommendations and Practices cervical cancer screening questionnaire adopted from the 
National Cancer Institute in collaboration with the Agency for Healthcare Research and Quality 
and Centers for Disease Control and Prevention (Appendix E). This survey applies validated 
instruments to assess clinicians’ “adoption of new or rapidly-evolving screening technologies 
and new screening guidelines, as well as their use of informed decision-making in discussing 
cancer screening with their patients, and practice-based systems that support and/or otherwise 
influence screening activities” (National Cancer Institute, 2019). The cervical cancer screening 
feature of this survey was utilized to identify providers’ practice patterns as well as knowledge of 
cervical cancer screening and management of abnormal Pap test results. Clinical vignettes were 
adopted from the validated survey as well as from current recommendations presented by the US 
Preventive Services Task Force (USPSTF) and the American Society for Colposcopy and 
Cervical Pathology (ASCCP). Clinical vignettes have been shown to be a valid and cost-effective 
method for assessing the quality and processes of clinical care, including cancer screening 
(Peabody et al, 2004). The questionnaire was approved by Advocate Aurora Health’s 
Institutional Review Board (IRB) and by the Research Subject Protection Program (RSPP).  
Of note: A portion of the National Survey of Primary Care Physicians’ Cancer Screening 
Recommendations and Practices is based on providers’ reports of their recommendations and 
practices. Self-reported data was not validated with other data sources such as medical records or 
claims. Formal permission to utilize this questionnaire was not required. Survey participation 
was voluntary. 
Provider education was initially intended to be delivered during an in-person staff 
meeting. Due to the COVID-19 pandemic, in-person staff meetings ceased. Instead, an 
education/training module was constructed and recorded using Microsoft PowerPoint. The 
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provider education module was designed based on gaps in knowledge identified on providers’ 
pre-intervention questionnaire responses. Information conveyed in the module covered the 2018 
US Preventive Services Task Force (USPSTF) cervical cancer screening guidelines as well as 
management of abnormal cervical cytology and histology results as recommended by the 
American Society for Colposcopy and Cervical Pathology (ASCCP). The education module was 
emailed to all providers along with a link for accessing the post-education questionnaire. All 
providers were emailed a reminder after 1 week to complete the questionnaire. The questionnaire 
was closed 2 weeks from the time it was sent. The questionnaire took approximately 20-30 
minutes to complete.  
Data Collection and Analysis 
Refer to Appendix F for the data collection/evaluation and analysis methods table, which 
summarizes the information detailed below. 
Patient Reminder Letters 
The following calculation was performed electronically to obtain cervical cancer 







Once received from the QIR, the aggregated monthly cervical cancer screening scores were 
entered and saved into a designated Excel spread sheet. Social Sciences Statistical Package 
Number of female patients 
ages 21-29 who had a 
minimum of one Pap test 
within the last 3 years plus 
the number of female 
patients age 30-64 who had 
a Pap cytology in the last 3 
years, or HPV or co-test in 
the past 5 years  
Total number of female 
patients age 21-64 with 
no history of 
hysterectomy who had at 
least 2 office visits in the 
last 36 months 
Cervical cancer 
compliance (%) 
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(SPSS) software was then used to generate a run chart to analyze cervical cancer scores over 
time. Through electronic query of the EMR, the QIR was also able to track the number of 
completed cervical cancer screenings among the 295 patients that received a reminder letter. 
Provider Education and Questionnaire  
Anonymous provider questionnaire responses were collected in a designated Excel spread 
sheet. Questions 7a-7g, 8a-8c, 11-20 on the survey were marked as either incorrect or correct. 
There were a total number of 20 questions that counted towards the overall score. Correct 
answers were given 1 point for a total possible score of 20. The total possible score out of 20 was 
calculated and expressed as a percent for each provider. Descriptive statistics (mean and standard 
deviation) were analyzed through SPSS software and compared after the pre- and post-education 
questionnaires were closed.  
Questions 1-6 and 9-10 focused on primary care providers' attitudes, recommendations, 
and practices toward use of established and emerging technologies as well as guidelines for 
cervical cancer screening. While the purpose of this project did not require further analysis of 
these questions, they were helpful in understanding the aforementioned factors that support 
and/or influence providers’ screening activities. A Likert scale was used to determine providers’ 
perception of efficacy among various cervical cancer screening procedures, degree of influence 
among various screening guidelines, as well as the level of agreement regarding the use of HPV 
DNA testing in predicting cervical cancer and the impact of HPV vaccination on cervical cancer 
screening practices. Question 21 was added to the post-education questionnaire to evaluate 
providers’ perceptions of change in knowledge and practice patterns after reviewing the 
education. 
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Ethical Considerations 
This DNP project was guided by ethical principles of autonomy, beneficence, non- 
maleficence and justice.  
Autonomy  
Patients received comprehensible written education about cervical cancer screening in 
order to foster informed decision-making. The right of the patient to decline medical care, 
including cervical cancer screening, is honored by all providers. All patient data for this study 
was collected as part of routine care (i.e. measuring and reporting provider performance data for 
clinic use), therefore regulations for the protection of human subjects did not apply. There was 
no burden placed on a patient beyond that of routine care, therefore there was no requirement for 
such activities to be conducted with patient informed consent. No individually identifiable 
patient data was accessible to the author for analysis. 
The author does not have any supervisory relationship with the providers at RiverCenter 
clinic. Providers were informed of the quality improvement interventions through an induction 
session. Prior to survey engagement, providers were notified of voluntary participation. No 
penalties or incentives were applied based on personal choice to respond, thus eliminating the 
threat of pressure or coercion. Survey completion implied provider consent.  
Beneficence and Non-maleficence  
Providers and patients at RiverCenter clinic were anticipated to benefit from this project, 
which aimed to improve the quality of patient care and outcomes while employing minimal risk 
to its participants. An objective of this project was to increase guideline-consistent cervical 
cancer screening rates, thereby reducing imposed patient risk associated with over and under-
screening practices. Furthermore, the organization’s Safe Care Promise was included in the 
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patient’s reminder letter in an effort to relay risk mitigation efforts in place during COVID-19. 
Interventions implemented in this project were consistent with evidence-based practice.  
All patients eligible to receive a reminder and educational letter were identified through 
electronic query of EMR data. In order to remain in compliance with the Health Insurance 
Portability and Accountability Act (HIPAA), letters did not contain any sensitive information for 
individual patients. Cervical cancer screening compliance rates were collected in aggregated 
form. Data collection and analysis was supervised by individuals who have been trained to carry 
out QI and clinical audit projects. Access to patient data was limited to involved staff at 
RiverCenter clinic. The EMR maintains an audit trail to ensure that patient data is obtained 
lawfully. Survey information provided by physicians and advanced-practice clinicians remained 
confidential and free of identifying data.  
Justice 
Inclusion and exclusion criteria for eligible patients did not comprise socioeconomic 
variables such as racial group, ethnic group, marital status, financial standing or level of 
education. This project endeavored to improve cervical cancer screening rates and appropriate 
follow-up irrespective of a population’s socio-demographic characteristics. 
Clinical Resources and Cost 
RiverCenter clinic has access to an organizational nursing research scientist as well as a 
quality improvement representative and an application support tech (IT) who assisted with data 
retrieval and management. These resources were utilized to ensure appropriate data elements 
were identified for measurement metrics. 
Time represents the greatest resource and “cost” as there was limited monetary 
expenditure for printing patient letters and educational brochures. Provider education was 
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electronically delivered at no cost. Meeting spaces were located within the practice setting and 
were widely available to use free of charge. Meetings with aforementioned team members and 
providers were held during work hours, therefore no over-time pay or extension of FTE was 
required.  
Results 
Patient Reminders Letters 
All 295 patient letters were delivered from 10/01/20 - 12/01/20 with 68 of those patients 
completing cervical cancer screening at the clinic. Following dissemination of patient reminder 
letters encompassing education and risk-mitigation efforts practiced during the COVID-19 
pandemic, the clinic’s overall cervical cancer screening score increased by 1% (Appendix G, 
Figure 1).  
According to the Medical College of Wisconsin Institute for Health and Equity & 
Wisconsin Electronic Disease Surveillance Systems (2021), a total of 9,460 COVID-19 cases in 
Milwaukee County have been identified since the first confirmed case on 03/06/20. Refer to 
Appendix G (Figure 2) for an extract of the daily incidence of new cases and the average daily 
incidence within the last 7 days (Wisconsin Electronic Disease Surveillance System, 2020). The 
highest daily case count since the beginning of the pandemic occurred on 11/09/20 with 1,689 
cases in Milwaukee County overall. At the time of data collection for all confirmed cases, 47% 
were male and 53% were female. Despite the escalation in COVID-19 cases and higher rate of 
infection among females, RiverCenter clinic achieved and maintained an increase in cervical 
cancer screening rates.  
Provider Education and Questionnaire 
Pre-education Provider Questionnaire  
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Eight out of ten eligible primary care providers at RiverCenter clinic completed the pre-
intervention questionnaire, which yielded an 80% response rate. Analysis of descriptive statistics 
(mean and standard deviation) revealed a mean provider score of 73.13% and a standard 
deviation of 8.84. Questions regarding frequency of routine cervical cancer screening based 
solely on age were answered correctly by 100% of providers. Less than 40% of the providers 
answered questions 8c, 11, 14, 17, and 20 correctly. These questions examined appropriate 
follow-up for women over 30 years of age with ASC-US, younger than 25 years of age with 
LSIL or higher, and screening guidelines for those who are immunocompromised as well as for 
women ages 65+. Refer to Appendix G (Figure 3) for the percentage of providers who answered 
each question or group of questions correctly on the pre-education questionnaire. 
In a typical month, the majority of providers personally order or perform cervical cancer 
screening with Pap testing on 1-10 asymptomatic average-risk female patients. One hundred 
percent of providers use liquid-based cytology for cervical cancer screening and order HPV 
testing either for routine or follow-up testing. Providers are more inclined to refer to Gynecology 
for management of patients age 30 years and older with abnormal Pap test results (ie ASC-US, 
HPV positive).  
Refer to Appendix G (Tables 1-3) for a summary of the following findings: Providers 
considered the U.S. Preventive Services Task Force to be the most influential cervical cancer 
screening guideline in their practice. Although there was variation in the perceived effectiveness 
of screening with conventional and liquid-based cytology in reducing cervical cancer mortality in 
average-risk women, 100% of providers agreed that HPV DNA with Pap test is very effective. 
The majority of providers strongly agreed that HPV DNA testing with Pap testing is more 
accurate than Pap test alone in predicting cervical cancer and that completion of the HPV 
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vaccine series does not impact when cervical cancer screening is initiated. One hundred percent 
of providers strongly disagreed that completing the HPV vaccine series impacts how often a 
patient is screened for cervical cancer.  
Post-education Provider Questionnaire  
Seven out of ten providers viewed the electronic training module and completed the post-
education questionnaire. Data revealed a mean provider score of 91.43% and standard deviation 
of 6.90. The post-education questionnaire score increased by 18% from baseline (Appendix G, 
Figure 4). An increase was noted in the percent of providers who answered each question or 
group of questions correctly following the educational intervention.  There was 1 question (#12) 
out of 20 questions total in which a decrease was found in the percent of providers who answered 
correctly; however, this finding was attributable to a decrease in the number of providers who 
completed the post-education questionnaire. Seventy-five percent, or 6 out of 8 providers, 
answered question 12 correctly on the pre-education questionnaire. Approximately 71%, or 5 out 
of 7 providers, answered question 12 correctly on the post-education questionnaire. Refer to 
Appendix G (Figure 5) for the percentage of providers who answered each question or group of 
questions correctly on the post-education questionnaire and Appendix G (Figure 6) for a 
comparison to the pre-intervention questionnaire. 
Six out of seven providers strongly agreed that their knowledge of cervical cancer 
screening and management of abnormal Pap results improved by reviewing the educational 
module. Three out of seven providers somewhat agreed and three of out seven providers strongly 
agreed that their practice patterns will change as a result of reviewing the education offered. A 
nonparametric Wilcoxon signed ranks test was performed through SPSS software to evaluate the 
impact of training on providers’ knowledge of cervical cancer screening as well as management 
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of abnormal cervical cytology and histology. Results of the Wilcoxon signed rank test revealed 
that the providers’ post-education knowledge scores were significantly higher than pre-education 
scores (z = 21, p = 0.02). Thus, a statistically significant improvement in providers’ knowledge 
of cervical cancer screening as well as management of abnormal cervical cytology and histology 
was observed following implementation of provider education.  
Discussion 
 Amid a global pandemic where preventive health and cancer screenings have largely 
been deferred, this project demonstrated a simple and cost-effective process for enhancing 
provider knowledge and communicating the need for cervical cancer screening. The clinic did 
not meet Healthy People’s 2020 objective of screening 93% of women for cervical cancer. 
Nevertheless, the clinic did achieve a modest increase in cervical cancer screening rates 
following implementation of reminder letters, which implies the value of messaging and clear 
communication to encourage overdue women to be screened. Increased guideline-consistent 
screening, rescreening and surveillance practices will ultimately reduce rates of cervical cancer 
incidence and death. Provider training has the potential to lessen variability in interpretation and 
management of screening results. Enhanced provider knowledge of current clinical guidelines 
could reduce over- and under-treatment of cervical abnormalities at the cellular level, thereby 
minimizing the risk of psychological stress and impairment to patients’ cervical health.  
Limitations 
A small sample size for the provider questionnaire limits inferences that can be made from 
data analysis. Survey responses were presented in aggregate form, which excluded the ability to 
compare pre- and post-questionnaire findings of the same provider. A short intervention and data 
collection interval makes it difficult to conclude that patient reminder letters are not considerably 
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effective. Furthermore, the socioeconomic status of patients was not identified hindering the 
ability to draw associations between letter reminders and other variables in Pap smear 
completion.  
Recommendations and Sustainability 
Given the minor increase in cervical cancer screening rates following implementation of 
patient reminder letters, an alternative screening method should be explored for patients who 
cannot or prefer not to have in-person appointments during the COVID-19 pandemic. Although 
not yet approved by the Food and Drug Administration (FDA), home-based HPV testing is a 
promising strategy for expanding accessibility of cervical cancer screening, especially in an era 
of social-distancing. According to Gupta et al. (2018), “self-sampling instead of clinician-
sampling has proven to be equally accurate, in particular for assays that use nucleic acid 
amplification techniques.” Several studies have shown that the majority of women who tested 
HPV-positive in a self-obtained sample will schedule an appointment for follow-up diagnosis 
and management (Gupta et al., 2018). Self-collected HPV testing would provide an opportunity 
for improved adherence to screening guidelines by eliminating some of the barriers to in-office 
cervical cancer screening including time, cost, and perceived distress of gynecological 
examinations.  
 Ongoing monitoring of cervical cancer screening rates and distribution of patient 
reminder letters is needed to ensure that improvements made will be sustained over time. It 
would be beneficial to conduct patient interviews about barriers and facilitators to screening in 
order to inform effective messaging. Additional strategies need to be explored to address 
compliance, health literacy and access-to-care barriers among a largely vulnerable patient 
population. In order to sustain up to date knowledge of cervical cancer screening guidelines, the 
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To achieving the objective 
Harmful 


































 New providers and medical assistants who are 
motivated to excel and eager to learn  
 Culture of teamwork and collaboration 
 Leadership has a clear vision of success and are 
committed to continuous growth of the organization  
 Clinical and administrative leaders prioritize 
interpersonal communication 
 Staff members are engaged in professional 
development 
 Experienced, diverse Registered Nurse staff 
 Increased appointment availability at clinic 
 Large clinic increases the opportunity for in-person 
meetings and educational sessions 
 Quality Improvement Representative and nursing 
research scientist for data analysis and management 
 Application support information technologist for 
data retrieval 
 Meaningful use of EMR 
 Safe Care Promise during COVID-19 
 
Weaknesses 
 COVID-19 has led to the expansion of telehealth or 
virtual care and the redeployment of several primary 
care providers  
 Preventive exams requiring an in-person appointment 
such a cervical cancer screening are being deferred 
 The system of care lacks standardization 
 Lack of consistent processes staff use to outreach or 
educate patients to ensure periodic care based on level 
of risk 
 Recent provider turnover increases the risk that 
patients will be lost to follow-up 
 Busy practice lessens availability of leadership 





































 Meet or exceed the targeted (top decile) 
performance for Wisconsin Collaborative for 
Healthcare Quality (WCHQ) and Aurora cervical 
cancer screening goals. 
 Further reduce the morbidity and mortality 
associated with cervical cancer. 
 Improvement of service capacities 
 Enhance patient/provider education 
 Reduce costs for inappropriate examination. 
 Increased interest in advancing cervical cancer 
control activities. 
 HPV DNA-based testing has changed the landscape 
of cervical cancer screening and prevention. 
 
Threats 
 Low socio-economic status group with subsequent 
large health disparities. 
 Relative underuse of primary care and overuse of 
hospital-based care. 
 Cultural and financial barriers to care. 
 Patient population with extensive active problem lists 
limits time spent addressing health maintenance 
topics. 
 











































confusion likely limit 
adherence to current 
evidence-based 
cervical cancer 
screening and health 
policy 
recommendations as 
well as contribute to 

















appropriate: Rate of 
screening intervals 
and methodology of 
testing consistent 




Survey as a 
research design 
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health center that 





families in Essex 
County, New Jersey. 
 
Six focus groups 
were conducted with 
5 to 10 participants 
each, for a total of 
44 women. One 
group was 
conducted with 
black women of 
Haitian descent  
(n = 8), while 
another included 
African immigrant 
women (n = 5). Two 
focus groups were 
held with black 
women from the 
English-speaking 
Caribbean (n = 12) 




women (n = 19).  
There was limited 
knowledge and 
confusion across 
ethnic groups about 
cervical cancer and 
its risk factors, the 
Pap test, and the 
human papilloma 
virus (HPV) and its 
association with 
cervical cancer.  
 
Barriers to cervical 
cancer screening 
included perceived 
cost, busy work 
schedule, fear of the 
unknown, lack of 





the importance of 
screening and 
knowing that 
screening helps to 
maintains one's 
personal health is a 
facilitator of cervical 
cancer screening. 
 
Having a doctor's 
recommendation was 
Knowledge of 
cervical cancer and 
its risk factors, the 
Pap test, and the 
human papilloma 
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 of paramount 
importance for 




inclusion of women 
of all ages in cervical 
cancer education 
because of the roles 









practice in Toronto, 
Canada. 
 




rates for cervical 
cancer was 60% 
among eligible 
women ages 21-69 
years. 
 
Specific number of 
women included in 
the study was not 
reported. 
 
Between March 2014 
and December 2016, 
the cervical cancer 
screening rate 
increased from 60% 





recall letters for 
patients signed by 
their physician, (2) 
inclusion of 
educational 
brochures with the 
mailed letter, (3) 
physician audit and 
feedback, and (4) 
improved point-of-









women age 21 to 
69 who had a Pap 
smear within the 






limiting the ability 
to assess the 
contribution of 
each method in 
increasing cancer 













37 articles with 
15,658 female 
participants in 
different parts of 
world were included 
in the review.  
 







on health behavior 
change theories 
could help to 
improve CCS 
behavior of women 
in different part of 
the world.  
Developing one’s 
knowledge and 
beliefs lead to the 
change of health 
behavior. Theory-







intervention can help 
to reduce barriers of 
CCS and 
subsequently can 
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example mailed or 
telephone reminders 
increased pap test 
usage by 18.8%  
5 Hills, R.L., 
Kulbok, P.A. 








study design.  
 
1,032 eligible 
female patients ages 
21-64 years 
receiving care at The 







of a clinical decision 
support system, (2) 
provider educational 
outreach, (3) patient 
reminder letters, and 










The number of 
under-screened 
patients was reduced 
by nearly half.  
 
There was a 
threefold decrease in 
patients screened 





































women aged 18 
through 65 years 
receiving care at 3 
separate primary 
care sites affiliated 




A clinical decision 
support tool with 
capabilities to 
identify high-risk 

















higher in the 
intervention group at 
23.7% (61/257) than 
the completion rate 
at 3.3% (17/516) in 
the control group 
(p < 0.001). 
 
Rate of test 
completion for 
high-risk patients 
who were overdue 
for screening or 
follow-up of 
abnormal Pap test, 



















527 insured women 














Rate of adherence 
to evidence-based 
recommendations 
for Pap testing 
Women in this 






the ability to 
Level I 
Quality A/B 
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This study was 
conducted within the 
Cancer Research 







systems, funded by 
the National Cancer 
Institute.  
45 % (n=241) of the 
women in this study 
had at least a 
bachelor’s degree. 
42% (n=222) re- 
ported their race as 
white, non-Hispanic. 
Percent reporting 
membership in other 
racial or ethnic 
categories were as 
follows: 18 % 
African–American 
(n=92); 14 % Asian 
or Pacific Islander 
(n=74); 18 % 
Hispanic (n=97); 
and 7 % other or 
multiple categories 
(n = 36) identified.  
cervical cancer 
screening.  
Women with higher 
health literacy were 
more likely to have 





in this population, 
suggesting that it has 
independent effects 
beyond those of 
access to care.  
Health educators and 
clinicians should be 
aware that women 










 generalize these 
findings to women 
in other systems.  
Generalizability 
may also be 
limited by the fact 
that women in this 
study were 
volunteers. These 
women may differ 
in statistically 
meaningful ways 
from women who 
did not participate.  
 
 





5 studies (RCT) 
involving a total of 
797 women who 
were exposed to 
cervical cancer 
education and 812 
women in the 
comparison group.  
 
 
Use of culturally 
sensitive educational 
materials, letters with 
fact sheets on 




invitation letters had 
a significant effect 





The proportion of 
eligible women 





during the trial. 
Failed to collect 
secondary 
outcome data on 




coverage and how 
these variables 
contributed to the 
screening rates in 
women of various 
socio-economic 
















and certified nurse 





Adherence to the 
2012 cervical cancer 
screening guidelines 
is poor due, in part, 
to a lack of provider 
knowledge of the 
guidelines. 
 
Knowledge of the 
2012 screening 
guidelines as 
demonstrated by a 
correct response to 
6 questions that ask 




for each patient 
scenario. 
 
Small sample size 
limited the ability 
to conduct 
subgroup analyses.  
 
There is no 
information on 
non-responders, 
who may have 
lower guideline 
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answers to 15 
questions re: how 
providers are 
screening patients 
(Pap smear alone vs 
cotesting) and the 
frequency at which 




Provider views of 
their practice in 
relation to the 
guidelines, 
including how often 
they adhere to the 
guidelines and 
reasons for not 
adhering to 
guidelines in each 
age group. 
 
Study used a self-
reported survey 
design to collect 
data on knowledge 
of the guidelines. 




based on their 
knowledge of the 
guidelines rather 
than based on a 











374 females <21 
years of age at 
Loyola University 






educate providers on 
cervical cancer 




The total number of 
Pap tests done on 
adolescents 
decreased by 34%. 
 
There was a decrease 
in the proportion of 





up for abnormal 









patients less than 
21 years of age. 
Proportion of co-










were very low, 









Because this was a 
retrospective 
review of all 
screened 
adolescents during 
a single calendar 
year rather than 




over a period, 
study is unable to 
control for 
changes in faculty 


















































Intervention 1:  
Patient reminder letters 
and monitoring of clinic’s 
cervical cancer screening 
(CCS) rate 
Overall clinic’s CCS 
compliance score (%) is 
generated monthly by the 









identifiable patient data 
to the selected Patient 
Service Representatives 
(PSR) 
Patients due for CCS will be sent 
a reminder letter comprising risk 
mitigation efforts in place and an 
educational brochure on cervical 
cancer screening. The reminder 
letter will communicate the 
recommended follow-up as well 
as instruction for how to schedule 
an appointment or how to notify 
RiverCenter clinic if follow-up 
was performed elsewhere 
 
Intervention 2:  




reminded to complete 
questionnaire after 1 
week and 
questionnaire is closed 
after 2 weeks 
Provider education 
module is created 





Eligible female patients 
are identified through 








Provider responses are 
collected for analysis 
Each provider 
electronically receives 
education module and 
post-education 
questionnaire 
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APPENDIX D 
 
PATIENT REMINDER LETTER 
 
Our records show that it is time for you to get a Pap test to protect you from cervical cancer. Please 
schedule an in-clinic appointment with your primary care by choosing one of the following methods: 
1. Call the clinic at 414-283-844. 
2. Log into the LiveWell app and select the appointments icon from the activities page then select 
schedule an appointment. 
3. Go to https://myadvocateaurora.org and log in with your username and password. Select visits 
then select schedule an appointment. 
If you have received a Pap test at another facility within the last 3-5 years, please contact RiverCenter 
clinic to find out the necessary steps to have this information forwarded to our clinic: 414-283-8444.  
 
RiverCenter clinic is cautiously beginning to reactivate services while also managing the evolving 
COVID-19 pandemic. We are dedicated to providing preventive healthcare, such as cervical cancer 
screening with Pap testing. As we resume routine in-person appointments, please be assured that your 
safety remains our highest priority. Enhanced procedures and protocols are in place so that you can 
receive in-person care as safely and effectively as possible.  
 
The Advocate Aurora Safe Care Promise is designed to build consumer confidence, encourage patients 
to seek care they need and support our team members. Everyone will go through a COVID-19 screening 
before entering our clinic. Anyone who enters our clinic wears a mask. If you do not have a mask, we will 
gladly provide it. Our rearranged waiting areas and staggered appointment times reduce traffic and create 
safe spaces. We have increased cleaning in all areas, including additional disinfectant for high-touch 
spaces. Our visitor policy has also been updated to include one support person for adult patients who 
require complex medical decision-making. For those with symptoms, we kindly ask that you stay home 
and reschedule your Pap smear.  
 
If you think you’ve been exposed to COVID-19 or are experiencing fever, cough or shortness of 
breath, start with our COVID-19 Symptom Checker or call 866-443-2584.  
 
Symptom Checker and COVID-19 Resource Center can be accessed at: 
https://www.advocateaurorahealth.org/coronavirus-disease-2019/ 
 






























Cervical Cancer Screening Questionnaire 
 
The following survey was adopted and modified from the National Survey of Primary Care Physicians’ Cancer 
Screening Recommendations and Practices, sponsored by the National Cancer Institute (NCI) in collaboration with 
the Agency for Healthcare Research and Quality (AHRQ) and Centers for Disease Control and Prevention. All 
information you provide in this survey will remain confidential. Your answers will be aggregated with those of other 
respondents. Participation is voluntary and there are no penalties to you for not responding.  
Survey instructions: Questionnaire contains Likert scale, multiple choice and two-group categorical data. Please 
select the corresponding answer(s) that best fit your current clinical practice. Assume all patients are otherwise 
healthy individuals with no history of immunocompromise or increased risk unless specified in the scenario. 
1. How effective do you believe the following screening procedures are in reducing cancer mortality in 
average-risk women?  
Very Effective Somewhat Effective     Not Effective     Not Sure 
a. Pap test (conventional cytology)  
b. Pap test (liquid-based cytology) 
c. HPV DNA test with Pap test 
2. In your clinical practice how influential are cervical cancer screening guidelines from the following 
organizations? 
     Very Influential   Somewhat Influential   Not Influential   Not Familiar 
              
a. U.S. Preventive Services Task Force 
b. American Cancer Society 
c. American College of Obstetricians & Gynecologists 
d. American Academy of Family Physicians 
e. American College of Physicians 
3. During a typical month, for how many asymptomatic, average-risk female patients do you personally order 






o More than 40 
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4. Do you order or perform Pap testing, or work with a Nurse Practitioner (NP) or Physician’s Assistant (PA) 
who orders or performs Pap testing for your female patients? Select all that apply. 
o I personally order Pap testing 
o I personally perform Pap testing 
o I work with an NP or PA who orders or performs Pap testing for my patients 
5. Which cytology method do you use most often for cervical cancer screening? 
o Liquid-based – specimen suspended in liquid solution (e.g., Thin Prep or SurePath) 
o Conventional cytology – smear spread on glass slide and fixed  
o Other 
6. Do you ever recommend Human Papilloma Virus (HPV) testing for your female patients? Select all that 
apply. 
o Yes, I recommend HPV testing with the Pap test for routine cervical cancer screening 
o Yes, I recommend HPV testing as a follow up test for an abnormal Pap test 
o No, I do not recommend HPV testing at all 
7. Assume that the following female patients present for a routine visit in your office. What would you be 
most likely to recommend for Pap testing at this visit? 
Answer choices for each of the following questions: 
o Pap annually 
o Pap every 3 years 
o Pap every 5 years 
o Pap + HPV testing annually 
o Pap + HPV testing every 3 years 
o Pap + HPV testing every 5 years 
o No Pap 
a. 18 year-old who has never had sexual intercourse and is presenting for her 1st gynecologic visit 
b. 18 year-old who had sexual intercourse for the first time 1 month ago and is presenting for her 1st 
gynecologic visit 
c. 18 year-old who first had sexual intercourse 3 years ago and is presenting for her 1st gynecologic visit 
d. 25 year-old who has had no new sexual partners in the last 5 years and 3 consecutive negative Pap tests 
e. 35 year-old who has had no new sexual partners in the last 5 years and 3 consecutive negative Pap tests 
f. 35 year-old whose cervix was removed last year during hysterectomy for symptomatic fibroids. Has no 
history of cervical, vaginal or vulvar dysplasia, and 3 consecutive negative Pap tests 
g. Healthy 66 year-old who has had no new sexual partners in the last 5 years and 3 consecutive negative Pap 
tests. Last Pap with HPV co-test was performed 3 years ago, which resulted negative 
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8. How often do you recommend Pap and HPV testing for the following 35 year-old female patients? The first 
number reflects the frequency of Pap testing (in years) and the second number reflects the frequency of HPV 
testing (in years). “0” indicates that you would not perform the test as part of screening or follow up. 
       5, 0 5,5 3,0 3,3 1,0 1,1 
a. HPV and Pap cytology this year were negative 
b. HPV is positive and Pap cytology is negative 
c. HPV is negative and Pap cytology shows ASC-US 
9. Indicate your level of agreement with the following statements. 
            Strongly Agree   Somewhat Agree   Somewhat disagree   Strongly Disagree 
a. HPV DNA testing with Pap testing  
is more accurate than Pap alone in  
predicting cervical cancer 
 
b. HPV vaccine will impact when I  
start cervical cancer screening among  
females who have been fully vaccinated  
with the HPV vaccine 
 
c. HPV vaccine will impact how often I  
screen for cervical cancer among females  




10. There are several types of practice settings in which cervical cancer screening and follow up can be 
handled. For the female patients below who are HPV positive and recently had a Pap test showing ASC-US, 
please indicate what you would typically do. 
     Manage in my own practice Refer to gynecology 
a. Premenopausal, < 30 years old 
b. Premenopausal, >+ 30 years old 
c. Postmenopausal 
11. A 24-year old (with no prior abnormal result) has a Pap result showing LSIL. What is the recommended 
follow up? 
o Colposcopy 
o Repeat Pap in 12 months 
o Screening with co-testing in 3 years 
o Screening with Pap testing in 3 years 
12. A 40 year-old (with no prior abnormal result) has normal Pap cytology with positive HPV. What is the 
recommended follow up? 
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o Repeat co-testing in 3 years 
o Colposcopy 
o Repeat co-testing in 12 months 
o Screening with co-testing in 5 years 
13. When should a Pap test be repeated if initial cytology returned unsatisfactory? 
o 10-12 months 
o 6-8 months 
o 1-2 weeks 
o 2-4 months 
14. A 24 year-old underwent colposcopy for HSIL, which revealed absence of CIN 2/3. What is the 
recommended follow up? 
o Repeat colposcopy and cytology every 6 months for 2 years 
o Repeat colposcopy and cytology every 12 months for 2 years 
o Repeat co-testing in 12 months 
o Repeat co-testing in 6 months 
15. A 34 year-old (with no prior abnormal result) undergoes Pap with HPV co-testing. Her result shows ASC-
US and HPV positive. What is the recommended follow up? 
o Colposcopy 
o Repeat co-testing in 3 years 
o Repeat co-testing in 12 months 
o Continue routine screening with co-testing in 5 years 




17. Select all that apply. Women ages 65+ should stop screening when: 
o 3 consecutive negative cytology tests 
o 2 consecutive negative co-tests/HPV tests within the past 10 years 
o 1 negative co-test/HPV test in the past 5 years regardless of prior Pap history 
18. A 45 year-old underwent a complete hysterectomy for cervical dysplasia. Screening should be continued 
with a vaginal swab. 
o True 
o False 
19. A 20 year-old woman should undergo cervical cancer screening if this individual is sexually active and has 
a history of HIV. 
o True 
o False 
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20. Pap with HPV co-test was performed on a 30 year-old with history of rheumatoid arthritis on 
immunosuppressant treatment. Result of cytology is normal and HPV is negative. How often should co-
testing be performed on this individual? 
o Annually until 3 consecutive results are normal 
o Every 3 years 
o Every 5 years 
The following question is present on the post-education questionnaire only: 
21. Indicate your level of agreement with the following statements 
           Strongly Agree   Somewhat Agree   Somewhat Disagree   Strongly Disagree 
a. My knowledge of cervical cancer  
screening and management of  
abnormal Pap results improved by  
reviewing the education offered 
 
b. My practice patterns will change  
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APPENDIX F 
 




















Does the use of 
patient reminder 
letters comprising 





reopening of a large 
metro family practice 
clinic in the wake of 
COVID-19? 
 
% of eligible female 
patients that have 
received Pap testing 
with either cytology 
alone or co-testing 




(the actual number of 
cervical cancer pap 
tests performed 
divided by the total 
number of eligible 
patients). 
 
% of patient reminder 
letters sent to eligible 
patients  
 
Number of patients 
who received a 
reminder letter that 
completed cervical 
cancer screening with 
Pap. 
Outcome EMR chart review All eligible 
female 
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Number of questions 
correct divided by 
total number of 
questions. Percentage 
will be calculated 
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and 2 male 
physicians  
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APPENDIX G 
 






















Note. The overall clinic’s cervical cancer screening rates (expressed in percentage) are shown 
from July 2020 to December 2020 with a 1% increase noted in October 2020 and maintained 
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Figure 2 
 
COVID-19 in Milwaukee County: Daily Incidence of New Cases (Bars) and Average Daily 





















Note. At the time of data collection, a total of 9,4609 COVID-19 cases in Milwaukee County had 
been identified since the first confirmed case on 03/06/20. The highest daily case count since the 




















Milwaukee County Daily Number of COVID-19 Cases 
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Figure 3 
 


















Note. Questions regarding frequency of routine cervical cancer screening based solely on age 
were answered correctly by 100% of providers. Less than 40% of the providers answered 
questions 8c, 11, 14, 17, and 20 correctly. These questions examined appropriate follow-up for 
women over 30 years of age with ASC-US, younger than 25 years of age with LSIL or higher, 


















































% of providers who answered question(s) correctly
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Figure 4 














Note. Eight out of ten providers completed the pre-education questionnaire with a mean score of 
73.12%, standard deviation of 8.84. Seven out of ten providers completed the post-education 
questionnaire with a mean score of 91.43%, standard deviation of 6.90.  The post-education 
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Figure 5 

























Note. An increase was noted in the percent of providers who answered each question or group of 
questions correctly following the educational intervention.  There was 1 question (#12) out of 20 
questions total in which a decrease was found in the percent of providers who answered 
correctly; however, this finding was attributable to a decrease in the number of providers who 



























































































% of providers who answered question(s) correctly
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Table 1 
Perceived Efficacy of Various Screening Procedures 
How effective do you believe the following screening procedures are in reducing cancer 
mortality in average-risk women? 
Procedure Very Effective Somewhat 
Effective 























HPV DNA test 











Perceived Influence of Various Screening Guidelines 
In your clinical practice how influential are cervical cancer screening guidelines from 
the following organizations? 
Guideline Very Influential Somewhat 
Influential 
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Table 3 
Perceived Accuracy of HPV DNA testing and the Impact of HPV Vaccination on Screening  
Indicate your level of agreement with the following statements. 
Guideline Strongly Agree Somewhat Agree Somewhat 
Disagree 
Strongly Disagree 
HPV DNA testing 
with Pap testing is 
more accurate 
















The HPV vaccine 
will impact when 
I start cervical 
cancer screening 
among females 
who have been 
fully vaccinated 


















The HPV vaccine 
will impact how 
often I screen for 
cervical cancer 
among females 
who have been 
fully vaccinated 
with the HPV 
vaccine 
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